Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2785 of 5804
-
Could a rapamycin cream help bring back skin color in vitiligo?
Symptom relief OngoingIn current Dermatology practice, options for vitiligo remain limited. The purpose of this study is to determine if once daily dosed topical rapamycin is effective for the treatment of patients with vitiligo. Participants will apply either 0.1% topical rapamycin or 0.001% topical …
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
AI could cut prostate MRI time while keeping accuracy
Diagnosis CompletedMR prostate exam is essential for the diagnosis, workup and follow-up of prostate cancer. It allows to detect subclinical prostate cancer following an increase in the level of PSA. The investigators can score the lesion according to the PIRADS classification and obtain an estimat…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 08:02 UTC
-
Nasal spray may offer fast hives relief without needles
Symptom relief CompletedDetermine the effect of ARS-1 on a patient reported pruritus/hive score
Phase: PHASE2 • Sponsor: ARS Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New drug OK-1 tested in patients with Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this research is to test the safety of the study drug (OK-1) and see what effects (good and bad) this drug has on patients with recurrent solid tumors.
Phase: PHASE1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New combo aims to ease symptoms in advanced lung cancer
Symptom relief Recruiting nowThis phase I trial aims to determine if it is safe to use palliative radiotherapy and lurbinectedin at the same time to treat small cell lung cancer that has spread outside of the chest and that has grown after being treated with chemotherapy (extensive stage). Lurbinectedin kill…
Phase: PHASE1 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Could a daily pill reduce arm swelling? new trial tests acebilustat
Disease control CompletedThis study is designed to investigate the response of unilateral upper extremity (arm) lymphedema, during pharmacologic treatment of lymphedema with oral placebo and oral acebilustat. Participants will receive "study drug" (Acebilustat or placebo), for 9 months. For 3 of these mo…
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Magnetic zaps to the spine could ease diabetic stomach troubles
Symptom relief OngoingThe global incidence of diabetes is rising. Gastroparesis is a significant complication of diabetes that results in debilitating symptoms and affects quality of life. Current treatment options for diabetic gastroparesis are limited. Significant visceral afferent neuropathy is ass…
Phase: PHASE1 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New program eases diabetes stress and boosts blood sugar control in young people
Symptom relief CompletedIn this 2-year randomized clinical trial, we will implement and assess the impact of a behavioral/psychoeducational intervention to reduce diabetes distress and improve glycemic outcomes in adolescents and young adults, aged 14-25 years, with T1D in order to optimize their short-…
Phase: NA • Sponsor: Joslin Diabetes Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
No-Equipment workout shows promise for diabetes control
Disease control CompletedThis research study proposes to quantify the efficacy of the novel high intensity body-weight circuit (HIBC) training intervention on metabolic profile, body composition, and health related fitness exercise in middle aged persons with type-2 diabetes (T2DM). This research project…
Phase: NA • Sponsor: Kennesaw State University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Could a single injection replace weeks of eye drops after retinal surgery?
Disease control Recruiting nowTo demonstrate that intraoperative use of subtenon triamcinolone acetonide at the time of surgery without postoperative eye drops is non-inferior to the regimen of postoperative eye drops following primary pars plana vitrectomy for retinal detachment.
Phase: PHASE4 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Robot vs. surgeon: which hernia fix gets you home faster?
Symptom relief Recruiting nowThis is a randomized trial comparing open retromuscular ventral hernia repair to robotic retromuscular ventral hernia repair.
Phase: NA • Sponsor: Lucas Beffa • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Freezing foot pain: new study tests cryoablation for Morton's neuroma
Symptom relief Recruiting nowMorton's neuroma is a benign thickening involving the plantar interdigital nerve, most common in middle aged women. Morton's neuroma is one of the most frequent diagnoses seen in the investigators podiatry clinic and is difficult to treat. These lesions cause a burning or shootin…
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New painkiller shows promise for post-surgery relief
Symptom relief CompletedThe primary objective is to evaluate the analgesic efficacy of PBK\_L1704 compared with placebo in patients with moderate to severe acute pain after bunionectomy.
Phase: PHASE3 • Sponsor: Pharmbio Korea Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
VR headsets could help teens beat the blues
Symptom relief CompletedMajor depressive disorder (MDD) is a prevalent and disabling mental health condition. A recent meta-analysis shows that across all forms of psychotherapy, only 43% of all depressive patients fully recover from MDD and relapse rates are high. Therefore, there is a strong need for …
Phase: NA • Sponsor: Claudi Bockting • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New shoulder implant shows promise in early study
Disease control CompletedEvaluation of the performance and safety of the Catalyst CSR Shoulder System with clinical and radiographic results at multiple time points through 24 months postoperatively This study will be a prospective multi-center study conducted in the United States.
Phase: NA • Sponsor: Catalyst OrthoScience • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Brain study targets motivation loss in depressed teens
Knowledge-focused CompletedThe goal of the ADEPT Study is to understand anhedonia in young people and how it changes based on treatments targeting the brain circuit underlying it. Anhedonia is a challenging mental health symptom that involves difficulty with motivation to experience pleasant events. This s…
Phase: PHASE4 • Sponsor: Erika Forbes • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
MRNA therapy gives immune cells a temporary boost against rare infection disease
Disease control Recruiting nowBackground: CGD is caused by a gene mutation. For people with CGD, their cells cannot kill germs well, so they can get frequent or life-threatening infections. Researchers want to see if a new procedure can help a person s cells kill germs for a short time. It uses messenger RNA…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New gel stent shows promise for glaucoma patients
Disease control CompletedGlaucoma is the second most common cause of blindness in the world, second only to cataracts. This study will assess how safe and effective a glaucoma gel stent is when implanted using the ab externo approach. Adverse events and intraocular pressure will be assessed. XEN45 is an…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Radioactive drug trial aims at rare eye cancer
Disease control OngoingThe primary aim of the study is to establish the maximum-tolerated dose (MTD) of 225Ac-MTI-201 in participants with metastatic uveal melanoma. The secondary aims are to describe the pharmacokinetics of 225Ac-MTI-201 and the toxic effects of 225Ac-MTI-201 in participants with meta…
Phase: PHASE1 • Sponsor: Modulation Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Fasting for clearer skin? study tests Time-Restricted eating for psoriasis
Symptom relief CompletedOur study aims to determine whether intermittent fasting (IMF) is a valid method to improve psoriasis and psoriatic arthritis (PsA) disease severity and quality of life. Patients within OSU Dermatology with psoriasis and/or psoriatic arthritis will be enrolled in a dietary interv…
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC